| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Validation States: |
|
MA TN |
| (30) |
Priority: |
13.11.2019 US 201962934576 P 22.01.2020 EP 20153112
|
| (43) |
Date of publication of application: |
|
13.07.2022 Bulletin 2022/28 |
| (73) |
Proprietors: |
|
- F. Hoffmann-La Roche AG
4070 Basel (CH) Designated Contracting States: AL CH CY CZ ES GB GR HR HU IE IS LI MC MK NO PL RS SK SM TR
- Roche Diabetes Care GmbH
68305 Mannheim (DE) Designated Contracting States: AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI
|
|
| (72) |
Inventors: |
|
- AYSIN, Benhur
Indianapolis, 46250 Indiana (US)
- BERG, Max
68305 Mannheim (DE)
- CHITTAJALLU, Siva
Indianapolis, 46250 Indiana (US)
- LIMBURG, Bernd
68305 Mannheim (DE)
|
| (74) |
Representative: Altmann Stößel Dick Patentanwälte PartG mbB |
|
Theodor-Heuss-Anlage 2 68165 Mannheim 68165 Mannheim (DE) |
| (56) |
References cited: :
WO-A1-2014/113770 WO-A2-2014/025415 US-A1- 2016 104 057
|
WO-A1-2014/113770 US-A1- 2014 072 189
|
|
| |
|
|
|
|